from Dreamers to Disruptors
a Medidata Podcast
This is a call to the world’s visionaries who made waves. The ones who gave themselves the green light to turn bold dreams into disruptive realities and shake up the status quo. Hear straight from industry leaders across tech, healthcare, and life sciences as they share their stories and innovations with us. This is from Dreamers to Disruptors, a Medidata podcast.
Available on:
Episode 4
AI Ethics, Patient Recruitment, and a New Vision for Clinical Data: Arnaub Chatterjee
Arnaub has experience working for private companies, the US government, and as a teacher at Harvard Medical School, giving him unparalleled insight into the AI technologies reshaping study design and helping us to draw valuable insights from the vast amounts of data captured by healthcare organizations.
Join Arnaub and Medidata CEO Anthony Costello as they take a deep dive into the cutting-edge of clinical data management. They explore Arnaub’s pioneering work in the early days of Medidata’s adoption of AI, how we can ensure that our models are reliable and unbiased, and our collective project to build an environment that leverages patient data between and beyond clinical trials.
Episode 3
AI, Decentralized Clinical Trials, and Paving the Way for New Technologies in Pharma: Marisa Co
Marisa Co has built a career based on intimate knowledge of every aspect of the pharmaceutical industry, giving her unparalleled insight into clinical trials and how to drive change in life sciences. Alongside senior roles at some of the biggest names in healthcare, her participation in the launch of Mytrus paved the way for decentralized clinical trials (DCTs).
Join Marisa and Medidata CEO Anthony Costello as they dive into the technologies that enable DCTs to give patients ownership of their clinical trial journeys, and the AI boom that is transforming every aspect of clinical research.
Episode 2
Alzheimer’s Treatments, Dementia Early Detection, and the Future of Central Nervous System Research: Brad O’Connor
As life expectancy increases and survival rates for cancer and heart disease improve, central nervous system (CNS) conditions are increasingly becoming a focus in healthcare. The search to treat Alzheimer’s disease and other forms of dementia grows every day as more people feel their impact.
Cogstate CEO Brad O’Connor has over 20 years of experience driving his company to expand our collective knowledge and ability to detect CNS diseases as we work towards a cure for dementia. He and Medidata CEO Anthony Costello explore this critical and challenging area of clinical research, plus the strides being made to advance it.
Episode 1
Women’s Health, Digital Therapeutics, and Driving Change in Pharma: Jessica Federer
As Bayer’s first Chief Digital Officer, Jessica Federer is a true pioneer in life sciences. An early driver of digital transformation in clinical research and a champion for women’s health, she has a unique grasp on the challenges we face, and the opportunities waiting to be realized.
Listen as Medidata CEO Anthony Costello sits down with Jessica to explore her exceptional career, from her work to uplift women’s voices in the industry and tackle gender-based inequalities in healthcare, to the potential of digital therapeutics and other emerging technologies.